Ozenoxacin
Topical treatment of superficial skin bacterial infections such as impetigo
- CAS No.
- 245765-41-7
- Indication Class
- Anti-infectives
- Patent Expiry
- To be assessed
- Therapeutic Area
- Anti-infective / Dermatology
- Labeled Purity
- 98%+
- Registration Readiness
- GMP/DMF
- Commercialization Tier
- API (Commercialized)
- Linked Intermediates
- 3 key intermediates available
Key Intermediates for This API
Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higher| Intermediate | CAS | Shared | Action |
|---|---|---|---|
| [6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]boronic acid | 446299-81-6 | — | |
| 5-broMo-N,3-diMethylpyridin-2-aMine | 245765-66-6 | — | |
| ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | 103877-51-6 | — |
Listing Logic · Why It's Worth Listing
A topical non-fluoroquinolone quinolone targeting resistant Gram-positive bacteria; its pediatric and local-use profile offers differentiation in OTC and pediatric markets.
Anti-infective / Dermatology · Marketed; available for immediate sourcing
GMP/DMF-ready; supports regulatory filing and audit in target markets
3 key intermediates available; scale-up and cost control manageable
Product Description
Ozenoxacin is a prescription topical antibiotic cream used to treat impetigo, a common and contagious bacterial skin infection.
Supply source: Unibest · Ozenoxacin, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.